BCAB vs SO · $5.9M cap vs P/E 22, rev $29.55B
Bioatla Inc (BCAB) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
BCAB currently screens at market cap $5.9M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the BCAB and SO stock pages for the full models.
Not investment advice.